Adaptive Biotechnologies (NASDAQ: ADPT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Adaptive Biotechnologies (NASDAQ: ADPT) through any online brokerage.
The latest price target for Adaptive Biotechnologies (NASDAQ: ADPT) was reported by Morgan Stanley on Friday, May 6, 2022. The analyst firm set a price target for 18.00 expecting ADPT to rise to within 12 months (a possible 131.36% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $7.78 last updated May 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for Adaptive Biotechnologies.
Adaptive Biotechnologies’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Adaptive Biotechnologies.
Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.